The UK‐PBC risk scores: derivation and validation of a scoring system for long‐term prediction of end‐stage liver disease in primary biliary cholangitis M Carbone, SJ Sharp, S Flack, D Paximadas, K Spiess, C Adgey, ... Hepatology 63 (3), 930-950, 2016 | 383 | 2016 |
Performance of the Glasgow-Blatchford score in predicting clinical outcomes and intervention in hospitalized patients with upper GI bleeding RV Bryant, P Kuo, K Williamson, C Yam, MN Schoeman, RH Holloway, ... Gastrointestinal endoscopy 78 (4), 576-583, 2013 | 164 | 2013 |
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score M Carbone, A Nardi, S Flack, G Carpino, N Varvaropoulou, C Gavrila, ... The lancet Gastroenterology & hepatology 3 (9), 626-634, 2018 | 133 | 2018 |
A novel prognostic model for transplant-free survival in primary sclerosing cholangitis EM de Vries, J Wang, KD Williamson, MM Leeflang, K Boonstra, ... Gut 67 (10), 1864-1869, 2018 | 119 | 2018 |
Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: an international cohort study EMG de Vries, M de Krijger, M Färkkilä, J Arola, P Schirmacher, ... Hepatology 65 (3), 907-919, 2017 | 94 | 2017 |
Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases KD Lynch, RW Chapman, S Keshav, AJ Montano-Loza, AL Mason, ... Clinical gastroenterology and hepatology 18 (1), 179-187. e6, 2020 | 85 | 2020 |
Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system EC Goode, AB Clark, GF Mells, B Srivastava, K Spiess, WTH Gelson, ... Hepatology 69 (5), 2120-2135, 2019 | 80 | 2019 |
Obeticholic acid—a new therapy in PBC and NASH RW Chapman, KD Lynch British medical bulletin 133 (1), 95-104, 2020 | 70 | 2020 |
Primary sclerosing cholangitis: a clinical update KD Williamson, RW Chapman British medical bulletin 114 (1), 53-64, 2015 | 66 | 2015 |
New therapeutic strategies for primary sclerosing cholangitis KD Williamson, RW Chapman Seminars in liver disease 36 (01), 005-014, 2016 | 62 | 2016 |
Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells NM Provine, B Binder, MEB FitzPatrick, A Schuch, LC Garner, ... Frontiers in immunology 9, 756, 2018 | 59 | 2018 |
Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis SM Slevin, LC Garner, C Lahiff, M Tan, LM Wang, H Ferry, B Greenaway, ... Journal of Crohn's and Colitis 14 (10), 1446-1461, 2020 | 35 | 2020 |
Are dominant strictures in primary sclerosing cholangitis a risk factor for cholangiocarcinoma? RW Chapman, KD Williamson Current hepatology reports 16, 124-129, 2017 | 30 | 2017 |
Effects of tumor necrosis factor antagonists in patients with primary sclerosing cholangitis CRH Hedin, G Sado, N Ndegwa, E Lytvyak, A Mason, A Montano-Loza, ... Clinical gastroenterology and hepatology 18 (10), 2295-2304. e2, 2020 | 29 | 2020 |
The use of biologics in patients with inflammatory bowel disease and primary sclerosing cholangitis KD Lynch, S Keshav, RW Chapman Current hepatology reports 18, 115-126, 2019 | 27 | 2019 |
further evidence for the role of serum alkaline phosphatase as a useful surrogate marker of prognosis in PSC. KD Williamson, RW Chapman Alimentary pharmacology & therapeutics 41 (1), 149-151, 2015 | 20 | 2015 |
Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications SP Yeap, H Harley, R Thompson, KD Williamson, J Bate, F Sethna, ... Journal of Gastroenterology and Hepatology 34 (2), 425-435, 2019 | 12 | 2019 |
International Primary Sclerosing Cholangitis Study Group (IPSCSG), Levy C. Effects of Vedolizumab in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Diseases KD Lynch, RW Chapman, S Keshav, AJ Montano-Loza, AL Mason, ... Clin Gastroenterol Hepatol 18 (1), 179-187, 2020 | 9 | 2020 |
Clinical triage for colonoscopy is useful in young women KD Williamson, K Steveling, G Holtmann, M Schoeman, JM Andrews Internal Medicine Journal 45 (5), 492-496, 2015 | 8 | 2015 |
Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study N Tan, N Ngu, T Worland, T Lee, T Abrahams, K Pandya, E Freeman, ... Hepatology International 16 (5), 1094-1104, 2022 | 7 | 2022 |